Rosemary Sleep Quality Randomized Trial: What the Evidence Says

Quick Answer

Rosemary Sleep Quality Randomized Trial has 2 source documents in the current Migaku evidence database. The strongest available sources in this first pass are systematic review, so conclusions should be framed as evidence-aware guidance rather than medical advice.

Key Takeaways

• This page is generated only from sources stored in the Migaku evidence knowledge base.
• Current evidence mix: 1 systematic review, 1 narrative review.
• Claims should be interpreted with the source type, study design, population, and publication date in mind.
• This article is educational and does not replace care from a qualified clinician.

Evidence Map

What The Sources Report

• Moreover, substance use, including alcohol and drug misuse, has emerged as both a coping mechanism and a risk factor that exacerbates MH problems and increases the likelihood of poor adherence to antiretroviral therapy (ART). [Muleya Carlos (2026); evidence level 1]
• Despite their growing popularity and demonstrated benefits, the empirical evidence on the effectiveness of these mHealth applications in improving access to MH services among AYPLHIV remains fragmented. [Muleya Carlos (2026); evidence level 1]
• However, traditional sedative-hypnotic medications such as benzodiazepines, while effective, are often associated with dependency and adverse effects (;;). [Ma Dongchuan (2026); evidence level 3]
• Frost et al., 2024 In summary, the prevalence of insomnia and its health implications prompt a reevaluation of the limitations associated with conventional pharmacotherapy. [Ma Dongchuan (2026); evidence level 3]

How To Read This Evidence

Evidence level 1 generally reflects systematic reviews or meta-analyses. Level 2 includes randomized trials, guidelines, or public-health guidance. Level 3 usually reflects observational or narrative-review evidence. Level 4 is weaker or early-stage evidence. The level is a sorting aid, not a final quality grade.

Practical Interpretation

There is at least one systematic-review style source in the current set, so it deserves more weight than single-study evidence. For rosemary sleep quality randomized trial, the next editorial step is to add more targeted sources and separate strong findings from early or indirect evidence.

Limits Of This First Pass

This is a small-batch MVP article. It uses the first ingested sources for this topic and should be expanded with more targeted searches, license review, and human editorial checks before being treated as a definitive review.

References

• Muleya Carlos (2026). Mobile health applications for enhancing mental health access and outcomes among adolescents and young people living with HIV: a systematic review. DOI: 10.1186/s12982-026-01998-9. PMCID: PMC13149599. PMID: 42109762. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC13149599/
• Ma Dongchuan (2026). Multi-target regulatory mechanisms and clinical assessment of natural products for insomnia: a review. DOI: 10.3389/fphar.2026.1681709. PMCID: PMC12847301. PMID: 41613780. License: CC BY 4.0. https://pmc.ncbi.nlm.nih.gov/articles/PMC12847301/

Safety Note

Health information can change, and individual risk depends on medical history, medications, pregnancy status, age, and diagnosis. Talk with a qualified clinician before changing treatment, supplement, or medication routines.